Erik Pettersson
Erik Pettersson
@erikpett123.bsky.social
A nice piece, I agree, but I wonder if it might be underselling the value of stimulants based on (relatively) small RCTs. Larger quasi-experimental register-based studies tend to find protective (short-term) effects pubmed.ncbi.nlm.nih.gov/31155139/
Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Da...
Attention-deficit/hyperactivity disorder (ADHD) medication is one of the most commonly prescribed medication classes in child and adolescent psychiatry, and its use is increasing rapidly in adult psyc...
pubmed.ncbi.nlm.nih.gov
April 14, 2025 at 7:34 AM
Perhaps these two (somewhat opposing) articles could be of use: psycnet.apa.org/record/1993-... and pubmed.ncbi.nlm.nih.gov/16393012/
APA PsycNet
psycnet.apa.org
December 31, 2024 at 6:41 PM
Wake Forest, at least in the past
September 20, 2024 at 6:23 PM
It’s obviously a very thorny issue to resolve, but for what it’s worth, we observed that the association between the p factor and later outcomes largely remained within twin and sibling pairs pubmed.ncbi.nlm.nih.gov/37163290/
December 3, 2023 at 8:40 AM